Diet-induced obesity predisposes anti-PD-1 antibody-treated mice to imiquimod-mediated psoriasiform dermatitis: implications for immune-related adverse events in cancer patients treated with anti-PD-1

被引：0
|
作者：
Yu, S. [1 ,2 ]
Wu, X. [2 ]
Shi, Z. [2 ]
Huynh, M. [2 ]
Hwang, S. T. [2 ]
机构：
[1] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung, Taiwan
[2] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
022
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer
    Yu, Sebastian
    Wu, Xuesong
    Shi, Zhenrui
    Huynh, Mindy
    Jena, Prasant Kumar
    Sheng, Lili
    Zhou, Yan
    Han, Dan
    Wan, Yu-Jui Yvonne
    Hwang, Samuel T.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 97 (03) : 194 - 200
  • [2] RISK FACTORS OF IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS TREATED WITH ANTI-PD-1 ANTIBODY PEMBROLIZUMAB
    Eun, Y.
    Kim, I. Y.
    Kim, H.
    Ahn, J. K.
    Park, E. -J.
    Hwang, J.
    Jeong, H.
    Chai, J. Y.
    Cha, H. -S.
    Koh, E. -M.
    Lee, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1205 - 1205
  • [3] Anti-PD-1 antibodies: immune-related adverse events and efficacy
    Reactions Weekly, 2019, 1739 (1) : 6 - 6
  • [4] Immune-related adverse events with resumed anti-PD-1 therapy
    Reactions Weekly, 2017, 1676 (1) : 4 - 4
  • [5] Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1)
    Cybulska-Stopa, Bozena
    Kaminska-Winciorek, Grazyna
    Dyduch, Grzegorz
    MELANOMA RESEARCH, 2020, 30 (06) : 619 - 624
  • [6] Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients
    Rogado, J.
    Romero Laorden, N.
    Sanchez Torres, J. M.
    Ballesteros Garcia, A. I.
    Pacheco-Barcia, V. E.
    Arranz, R.
    Mondejar Solis, R.
    Gullon, P.
    Lorenzo, A.
    Colomer Bosch, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Cutaneous immune-related adverse events in 1,857 patients treated with anti-PD-1 therapy at an academic center
    Le, T.
    Kaul, S.
    Cappelli, L.
    Naidoo, J.
    Kwatra, S. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S108 - S108
  • [8] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    John A. McCulloch
    Diwakar Davar
    Richard R. Rodrigues
    Jonathan H. Badger
    Jennifer R. Fang
    Alicia M. Cole
    Ascharya K. Balaji
    Marie Vetizou
    Stephanie M. Prescott
    Miriam R. Fernandes
    Raquel G. F. Costa
    Wuxing Yuan
    Rosalba Salcedo
    Erol Bahadiroglu
    Soumen Roy
    Richelle N. DeBlasio
    Robert M. Morrison
    Joe-Marc Chauvin
    Quanquan Ding
    Bochra Zidi
    Ava Lowin
    Saranya Chakka
    Wentao Gao
    Ornella Pagliano
    Scarlett J. Ernst
    Amy Rose
    Nolan K. Newman
    Andrey Morgun
    Hassane M. Zarour
    Giorgio Trinchieri
    Amiran K. Dzutsev
    Nature Medicine, 2022, 28 : 545 - 556
  • [9] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    McCulloch, John A.
    Davar, Diwakar
    Rodrigues, Richard R.
    Badger, Jonathan H.
    Fang, Jennifer R.
    Cole, Alicia M.
    Balaji, Ascharya K.
    Vetizou, Marie
    Prescott, Stephanie M.
    Fernandes, Miriam R.
    Costa, Raquel G. F.
    Yuan, Wuxing
    Salcedo, Rosalba
    Bahadiroglu, Erol
    Roy, Soumen
    DeBlasio, Richelle N.
    Morrison, Robert M.
    Chauvin, Joe-Marc
    Ding, Quanquan
    Zidi, Bochra
    Lowin, Ava
    Chakka, Saranya
    Gao, Wentao
    Pagliano, Ornella
    Ernst, Scarlett J.
    Rose, Amy
    Newman, Nolan K.
    Morgun, Andrey
    Zarour, Hassane M.
    Trinchieri, Giorgio
    Dzutsev, Amiran K.
    NATURE MEDICINE, 2022, 28 (03) : 545 - +
  • [10] Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients
    Rogado, J.
    Sanchez-Torres, J. M.
    Romero-Laorden, N.
    Ballesteros, A., I
    Pacheco-Barcia, V
    Ramos-Levi, A.
    Arranz, R.
    Lorenzo, A.
    Gullon, P.
    Donnay, O.
    Adrados, M.
    Costas, P.
    Aspa, J.
    Alfranca, A.
    Mondejar, R.
    Colomer, R.
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 21 - 27
12345